Search research articles
Contact Us
Filters
Showing results (211-220 of 265) with videos related to
Page
of 27
Sort By:
Breast Cancer Research : BCR
|
February 18, 2016
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer
H Raza Ali, Aliakbar Dariush, Elena Provenzano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial
H M Earl, L Hiller, J A Dunn, et al.
Science Advances
|
January 31, 2025
Mechanisms of uropathogenic <i>E. coli</i> mucosal association in the gastrointestinal tract
Philippe N Azimzadeh, George M Birchenough, Nathaniel C Gualbuerto, et al.
The Lancet. Oncology
|
December 24, 2013
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial
Helena M Earl, Anne-Laure Vallier, Louise Hiller, et al.
The Lancet. Oncology
|
July 3, 2020
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial
Sarah P Blagden, Adrian D Cook, Christopher Poole, et al.
Nature Communications
|
November 2, 2024
Distinct Escherichia coli transcriptional profiles in the guts of recurrent UTI sufferers revealed by pangenome hybrid selection
Mark G Young, Timothy J Straub, Colin J Worby, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
Distinct <i>Escherichia coli</i> transcriptional profiles in the guts of recurrent UTI sufferers revealed by pangenome hybrid selection
Mark G Young, Timothy J Straub, Colin J Worby, et al.
The Journal of Biological Chemistry
|
June 11, 2020
The mitochondrial metal transporters mitoferrin1 and mitoferrin2 are required for liver regeneration and cell proliferation in mice
Alexandra Seguin, Xuan Jia, Aubree M Earl, et al.
Scientific Reports
|
July 26, 2019
Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer
Surrin S Deen, Andrew N Priest, Mary A McLean, et al.
Journal of the National Cancer Institute
|
May 1, 2016
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
John M S Bartlett, Jane Bayani, Andrea Marshall, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 265) with videos related to
Sort By:
Page
of 27
Breast Cancer Research : BCR
|
February 18, 2016
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer
H Raza Ali, Aliakbar Dariush, Elena Provenzano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial
H M Earl, L Hiller, J A Dunn, et al.
Science Advances
|
January 31, 2025
Mechanisms of uropathogenic <i>E. coli</i> mucosal association in the gastrointestinal tract
Philippe N Azimzadeh, George M Birchenough, Nathaniel C Gualbuerto, et al.
The Lancet. Oncology
|
December 24, 2013
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial
Helena M Earl, Anne-Laure Vallier, Louise Hiller, et al.
The Lancet. Oncology
|
July 3, 2020
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial
Sarah P Blagden, Adrian D Cook, Christopher Poole, et al.
Nature Communications
|
November 2, 2024
Distinct Escherichia coli transcriptional profiles in the guts of recurrent UTI sufferers revealed by pangenome hybrid selection
Mark G Young, Timothy J Straub, Colin J Worby, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
Distinct <i>Escherichia coli</i> transcriptional profiles in the guts of recurrent UTI sufferers revealed by pangenome hybrid selection
Mark G Young, Timothy J Straub, Colin J Worby, et al.
The Journal of Biological Chemistry
|
June 11, 2020
The mitochondrial metal transporters mitoferrin1 and mitoferrin2 are required for liver regeneration and cell proliferation in mice
Alexandra Seguin, Xuan Jia, Aubree M Earl, et al.
Scientific Reports
|
July 26, 2019
Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer
Surrin S Deen, Andrew N Priest, Mary A McLean, et al.
Journal of the National Cancer Institute
|
May 1, 2016
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
John M S Bartlett, Jane Bayani, Andrea Marshall, et al.
Page
of 27